Accessibility settings

This paper is in the following e-collection/theme issue:

News and Perspectives (131)

Published on in Vol 28 (2026)

Young man in a suit smiling confidently

US Food and Drug Administration Shifts to AI-Enhanced Regulatory Review With Elsa 4.0 and HALO

US Food and Drug Administration Shifts to AI-Enhanced Regulatory Review With Elsa 4.0 and HALO

Authors of this article:

Tejas S Athni, JMIR Correspondent
Article Cited by (1) Tweetations Metrics

Journals

  1. Lucas I, Sousa J, Vitorino C. Artificial Intelligence in Pharmaceutical Regulatory Science: Opportunities, Challenges, and Emerging Frameworks. The AAPS Journal 2026;28(6) View